Premium
Singapore state investment firm Temasek has taken a haircut by partially exiting an Indian company, in another instance of a bet that didn't likely yield the desired returns. Temasek sold a 0.44% stake--a little over a tenth of its holdings--in Glenmark Pharmaceuticals Ltd during the October-December quarter, stock-exchange filings show. It took ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
